| __timestamp | Eli Lilly and Company | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 56292000 |
| Thursday, January 1, 2015 | 4796400000 | 74277000 |
| Friday, January 1, 2016 | 5243900000 | 122721000 |
| Sunday, January 1, 2017 | 5281800000 | 109749000 |
| Monday, January 1, 2018 | 5051200000 | 145283000 |
| Tuesday, January 1, 2019 | 5595000000 | 131711000 |
| Wednesday, January 1, 2020 | 6085700000 | 181157000 |
| Friday, January 1, 2021 | 7025900000 | 272744000 |
| Saturday, January 1, 2022 | 7190800000 | 397518000 |
| Sunday, January 1, 2023 | 9313400000 | 571011000 |
| Monday, January 1, 2024 | 14271000000 |
Data in motion
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Eli Lilly and Company and Insmed Incorporated have showcased contrasting trajectories in their R&D investments.
Eli Lilly has consistently ramped up its R&D spending, with a remarkable 97% increase from 2014 to 2023. This strategic investment underscores their commitment to pioneering new treatments and maintaining a competitive edge. By 2023, their R&D expenses soared to nearly $9.3 billion, reflecting their robust pipeline and ambitious growth plans.
In contrast, Insmed Incorporated, while smaller in scale, has also shown a commendable increase in R&D spending, growing by over 900% during the same period. This growth highlights their dedication to innovation, albeit on a more modest scale compared to industry giants like Eli Lilly.
Analyzing R&D Budgets: Eli Lilly and Company vs Zoetis Inc.
Research and Development Investment: Eli Lilly and Company vs argenx SE
Research and Development: Comparing Key Metrics for Eli Lilly and Company and BeiGene, Ltd.
R&D Insights: How Eli Lilly and Company and Verona Pharma plc Allocate Funds
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Amicus Therapeutics, Inc.
Eli Lilly and Company or Soleno Therapeutics, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and MiMedx Group, Inc.
Analyzing R&D Budgets: Johnson & Johnson vs Insmed Incorporated
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Insmed Incorporated
Bristol-Myers Squibb Company or Insmed Incorporated: Who Invests More in Innovation?
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending